34 results about "Valine methyl ester" patented technology

This invention relates to a new synthetic method of valsartan, includes preparation method of intermediate N - ( 1 - oxygen amyl) - N - [ [ 2' - trityl - tetrazolium - 5 - group) - ( 1, 1' - dibenzyl) - 4 - group] - methyl] - L - valine. 2' - ( N - trityl) tetrazolium - 4 - bromoethyl Biphenyl and valine methyl ester ( or other salt) carry out alkylation reaction, after acidylation, by alkaline hydrolysis and acidification to obtain intermediate N - ( 1 - oxygen amyl) - N - [ [ 2' - trityl - tetrazolium - 5 - group) - ( 1, 1' - dibenzyl) - 4 - group] - methyl] - L - valine, then by protection solution to gain Valsartan. This invention belong to pharmaceutical chemistry and organic chemistry region, possess merits of raw material stabilization, yield higher, valsartan optical purity high, industrialization operating easy and so on.

The invention provides an improved process for synthesizing valsartan. According to the method, N-[(2'-cyano-1, 1'-diphenyl-4-yl) methyl]-L-valine methyl ester hydrochloride is used as a starting raw material and is subjected to improved control of acylation reaction, cyclization reaction, hydrolysis reaction and a crystallization process respectively to obtain high-purity valsartan. The process has the advantages of continuous and simple process operation, high yield and purity and suitability for industrial production.

The invention discloses an improved method for preparing valsartan. According to the invention, certain steps required for preparing the valsartan in certain patents in the past are improved. The improved method comprises the following steps of: adding (N-(1-valeryl)-N-[4-[2-(5-cyan)-phenyl]benzyl]-L-valine methyl ester valsartan, sodium azide, triethylamine hydrochloride and a solvent into a reactor, and directly performing diazotization reaction; adding a sodium hydroxide solvent for saponification reaction after the diazotization reaction; and purifying the obtained product to finally obtain the valsartan product with high purity. According to the method, the diazotization reaction time is short, the loss of energy is reduced, the reaction process is environment-friendly, the yield and the purity of the product are high, the industrial production cost is greatly reduced, and the industrial production is easily realized.

The invention provides a preparation method of LZ969. According to the preparation method, LZ969 is used for representing a compound of valsartan and 4-(((2S, 4R)-1-(1, 1'-biphenyl-4-yl)-5-ethoxy-4-methyl-5-oxo pentane-2-yl) amino)-4-oxo butyric acid at a molar ratio of 1:1. A preparation method of valsartan comprises following steps: L-valine methyl ester hydrochloride is synthesized; nucleophilic substitution is carried out so as to obtain N-[2'-cyano-(biphenyl-4-yl)-methyl]-L-valine methyl ester hydrochloride; valeryl chloride is added, sodium carbonate is taken as an acid-binding agent, acetone is taken as a solvent, and N-[2'-cyano-(biphenyl-4-yl)-methyl]-N-valeryl is obtained via reaction; and N-[2'-cyano-(biphenyl-4-yl)-methyl]-N-valeryl, sodium azide, and chloro-substituted tributyltin are subjected to heating reaction by taking pyridine as a solvent so as to obtain valsartan. Technical route reaction of the preparation method is mild; operation is simple; and yield is high.

The invention discloses a preparation method of L-valine methyl ester hydrochloride, which comprises the following steps of: firstly, adding absolute methanol in a reactor and controlling the temperature between 8 DEG C below zero and 10 DEG C below zero, dripping thionyl phthalyl chloride by stirring, reacting for 0.8-1.5 hours at the temperature, adding L-valine under the cooling condition, raising the temperature to the ambient temperature and stirring for 2.5-3.5 hours, then heating and refluxing, and reacting for 7-9 hours at the temperature of 60-70 DEG C; and secondly, reducing pressure to distill after the reaction, cooling residues for crystallization, carrying out vacuum filtration, and recrystallizing with absolute methyl-ethyl ether to prepare L-valine methyl ester hydrochloride, wherein the reaction materials have the mole ratio that n (L-valine):n (SOC12):n (absolute methanol)=1.0:1-1.5:20-21. The preparation method of the invention is simple, has fewer steps and small economic investment, and only requires commonly-used devices, and the prepared L-valine methyl ester hydrochloride is high in purity and yield and can satisfy the use requirements.

The invention discloses a sodium tetraphenylborate-based enantiomer potential sensor and an application of the enantiomer potential sensor in detection of valinemethyl ester. The sodium tetraphenylborate-based enantiomer potential sensor is characterized in that sodium tetraphenylborate, a plasticizer and PVC are dissolved in tetrahydrofuran to prepare a PVC membrane, a step of air drying is carried out, one sheet of the PVC membrane is sliced to paste on one end of a PVC pipe, a filling liquid is injected in the pipe, an Ag/AgCl internal reference electrode is inserted to obtain a PVC membrane electrode, and the membrane electrode forms the enantiomer potential sensor with a calomel electrode. The enantiomer potential sensor is used for detecting a leucinemethyl ester enantiomer. According to the invention, the linearity range is 10<-4>-10<-1> mol<-1>, the slope is -47mV dec<-1>, the LOD(limit of detection) is 3.311*10<-4> mol L<-1>, the electrode enables chiral detection on valinemethyl ester, and the antipodal selective coefficient 1g(img file='DDA0000439081610000011.TIF' wi='160' he='71' /) is -2.36. The sodium tetraphenylborate-based enantiomer potential sensor and the application of the enantiomer potential sensor in detection of valinemethyl ester have the advantages of rapidity, economy, environmental protection, simple equipment and convenient operation, and can be used for on-site determination.

The invention discloses a betulinic acid-amino acid derivative represented by a formula (I) and a preparation method thereof. The preparation method comprises the following steps of carrying out acylation reaction on a compound represented by a formula (a), acetic anhydride and pyridine under the protection of nitrogen so as to obtain a compound represented by a formula (b), reacting the compound of the formula (b) with oxalyl chloride so as to obtain a compound represented by a formula (c), then, respectively reacting the compound of the formula (c) with glycino methyl ester, L-alanine methyl ester, L-valine methyl ester, L-isoleucine methyl ester and L-glutamic acid methyl ester so as to obtain a compound represented by a formula (d), and washing, drying and purifying after reacting the compound of the formula (d) with LiOH so as to obtain the betulinic acid-amino acid derivative represented by the formula (I). The preparation method is high in synthetic efficiency and simple and convenient in process. The invention further discloses application of the betulinic acid-amino acid derivative represented by the formula (I) in preparation of a drug for treating osteoporosis; and the betulinic acid-amino acid derivative can be used as an osteoclast precursor differentiation inhibitor and has the obviously increased osteoclast precursor differentiation activity inhibition effect.

The invention discloses a preparation method of 2-bromothiophene, relates to a method for improving thiophene 2-site substitution selectivity and reducing the generation amount of 3-bromothiophene, and belongs to the technical field of preparation of fine chemical products such as medicines. The method is characterized in that thiophene is converted into 2-bromothiophene in the presence of L-valine methyl ester. The preparation method comprises the steps of adding sodium bromide, L-valine methyl ester and water, adding sulfuric acid, adding thiophene, and adding hydrogen peroxide. The reactionformula is shown in the attached drawing. The method has the advantages of being high in thiophene 2-sit substitution selectivity, small in 3-bromothiophene generation amount, environmentally friendly and low in cost.

The invention discloses a heterogeneous synthetic method and application of a Ritonavir intermediate. The heterogeneous synthetic method comprises the following steps: dissolving L-valine methyl ester hydrochloride and triphosgene in dichloromethane by utilizing a heterogeneous method; adding inorganic alkali liquor dropwise at a low temperature to generate isocyanate compounds; adding 2-isopropyl- 4-(methyl amino methyl) thiazole into a pot without separating to obtain N-((N-methyl-N-((2-isopropyl-4-thiazolyl)methyl)amino)formyl)methyl-L-valine. According to the heterogeneous synthetic method, one-pot synthesis of the Ritonavir intermediate MTV methyl ester is realized; all products can be purified through pulping and crystallizing; the purity of the products is higher than 98 percent. The pollution in a production process is low; the heterogeneous synthetic method has low harm to an operator, and is beneficial to environment, easy to operate, and particularly suitable for large-scale industrial production.

The invention discloses a valsartan impurity and a preparation method of the valsartan impurity. The valsartan impurity has a structure shown as formula I as shown in the specification. The preparation method of the valsartan impurity comprises the following steps: a) allowing a compound, N-((2'-cyan-[1,1'-biphenyl]-4) methyl)-L-valine methyl ester hydrochloride as a starting material and alkali to give an esterification reaction in a solvent and then performing acidification to prepare a compound shown as formula II as shown in the specification, and b) allowing the compound shown as the formula II and sodium nitrite in an organic solvent to be subjected to nitrosation under an acidic condition to form the valsartan impurity shown as the formula I. The preparation method is mild in reaction condition, simple in technology, short in reaction time and good in yield; the high-purity valsartan impurity shown as the formula I is obtained; a reliable impurity control is provided for qualitycontrol research of a valsartan product; and the valsartan impurity has very important significance.

The present invention provides a method for the preparation of N-(1-oxopentyl)-N-[[2′-(1H-tetra-zol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-L-valine (Valsartan) which comprises; treating N-[[2′-(1-triphenylmethyl-tetra-zol-5-yl)biphenyl-4-yl]methyl]-L-valine methyl ester (X) with oxalic acid or its hydrates in a solvent to produce N-[[2′-(1-triph-enylmethyl-tetrazol-5-yl)biphenyl-4-yl]methy]-L-valine methyl ester oxalate (Xa) and treating the compound (Xa) with a base in a solvent followed by reacting with valeryl chloride in presence of base in a solvent to produce N-[[2′-(1-triphenylmethyl-tetra-=zol-5-yl)[1,1′biphenyl]-4-yl]methyl]-N-valeryl-L-valine methyl ester (XI), de-protecting the compound (XI) using anhydrous acidic conditions to produce N-(1-oxopentyl)-N-[[2′-(1-H-tetrazol-5-yl)[1,1′biphenyl]-4-yl]methyl-L-valine methyl ester (V) followed by <treating with base in a solvent to produce Valsartan.

The invention relates to a synthesis process of valsartan, belonging to the technical field of medicine synthesis. The synthesis process comprises the following steps: mixing DMF, L-valine methyl ester hydrochloride and N,N-diisopropylethylamine, carrying out magnetic stirring at 5 DEG C, dropwise adding n-valeryl chloride, and conducting stirring at a room temperature for a reaction for 1.5 hours after dropwise adding to obtain an intermediate product a; producing an intermediate product b from the intermediate product a and N-(triphenylmethyl)-5-(4'-bromomethylbiphenyl-2-yl)tetrazole under the action of a hydrogen pulling agent and a condensing agent; and subjecting the intermediate product b to protection group removal and ester group hydrolysis to obtain a crude valsartan product, and finally, carrying out chiral separation to obtain the valsartan target product with a high S-enantiomer content. According to the invention, an existing raw material is used as a substrate, so generation of impurities is reduced, a synthesis route is shortened, product purity is improved, and production efficiency is improved; and moreover, reaction conditions are mild, and the process is an efficient valsartan synthesis process.